CEO Treace stated, "we are not growing our line the way we anticipated for the year," while also noting case volume growth in Q3 2025 was still below original expectations and driven by lower-ASP ...

Lapiplasty: A proprietary system addressing all dimensions of bunion deformity via a surgical procedure, typically for severe cases in the lapidus segment. MIS (Minimally Invasive Surgery) Osteotomy: ...

Trip Taylor: Good afternoon, everyone, and welcome to our third quarter 2025 earnings conference call. Participating from the company today will be John Treace, Chief Executive Officer; and Mark Hair, ...

Treace Medical Concepts Inc. (TMCI) reported its Q3 2025 financial results, showing an 11% year-over-year revenue growth to $50.2 million. Despite this growth, the company posted a net loss of $16.3 ...

John Treace, Chief Executive Officer, and Mark Hair, Chief Financial Officer. John and Mark will discuss our third quarter financial results and updated 2025 outlook. We'll then host a question and ...

Treace Medical Concepts, Inc. ((TMCI)) has held its Q3 earnings call. Read on for the main highlights of the call. The recent earnings call for Treace Medical Concepts, Inc. presented a mixed ...